These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35117920)
1. Neutrophil-lymphocyte ratio as a prognostic factor for stereotactic body radiotherapy treatment of metastatic liver tumors. Xie X; Shan J; Zhou X; Liu H; Sun X Transl Cancer Res; 2020 Sep; 9(9):5566-5573. PubMed ID: 35117920 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer. Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy. Park Y; Chang AR Korean J Gastroenterol; 2022 Jun; 79(6):252-259. PubMed ID: 35746839 [TBL] [Abstract][Full Text] [Related]
4. Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Hsiang CW; Huang WY; Yang JF; Shen PC; Dai YH; Wang YF; Lin CS; Chang WC; Lo CH J Hepatocell Carcinoma; 2021; 8():1299-1309. PubMed ID: 34765571 [TBL] [Abstract][Full Text] [Related]
5. Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience. Luo H; Ge H; Cui Y; Zhang J; Fan R; Zheng A; Zheng X; Sun Y J Cancer; 2018; 9(1):182-188. PubMed ID: 29290784 [No Abstract] [Full Text] [Related]
6. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study. Piao MN; Xie J; Jin MM; Ma XT; Dou Z; Wang JP; Li JL Transl Lung Cancer Res; 2024 Aug; 13(8):1950-1963. PubMed ID: 39263027 [TBL] [Abstract][Full Text] [Related]
8. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy. Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985 [No Abstract] [Full Text] [Related]
9. The prognostic value of red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in radiotherapy for oropharyngeal cancer. Staniewska E; Tomasik B; Tarnawski R; Łaszczych M; Miszczyk M Rep Pract Oncol Radiother; 2021; 26(6):1010-1018. PubMed ID: 34992875 [TBL] [Abstract][Full Text] [Related]
10. Pre/Post-Treatment Dynamic of Inflammatory Markers Has Prognostic Value in Patients with Small Hepatocellular Carcinoma Managed by Stereotactic Body Radiation Therapy. Zhuang Y; Yuan BY; Hu Y; Chen GW; Zhang L; Zhao XM; Chen YX; Zeng ZC Cancer Manag Res; 2019; 11():10929-10937. PubMed ID: 32099457 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882 [No Abstract] [Full Text] [Related]
12. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
13. The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma. Aktepe OH; Güner G; Güven DC; Şahin TK; Ardıç FS; Yüce D; Yalçın Ş; Erman M Turk J Med Sci; 2021 Apr; 51(2):757-765. PubMed ID: 33350295 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy. Miao Y; Yan Q; Li S; Li B; Feng Y Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290 [TBL] [Abstract][Full Text] [Related]
15. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy. Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy. Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619 [TBL] [Abstract][Full Text] [Related]
17. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933 [TBL] [Abstract][Full Text] [Related]
18. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery. Yu J; Ding Z; Yang Y; Liu S Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254 [TBL] [Abstract][Full Text] [Related]
20. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy]. Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]